This article from the Sun-Times newspaper addresses the amount of teenage girls, ages 13 to 17, who received the three series vaccination that attacks the Human Papillomavirus (HPV). The study is the first to track the rate of the Gardasil vaccine. Out of the 3,000 teens that were studied about twenty five percent got at least one Gardasil shot. The researchers were hoping for a much higher rate.
Along with studying how many received the vaccination for HPV, the study also took a look at other teen vaccination rates. These vaccinations included meningitis; one shot that guarded against diphtheria, whooping cough, and tetanus; varicella, hepatitis B, measles, mumps, and rubella (“1 in 4 teen girls,” 2008). All of these vaccinations had an increase in their rates. These shots were recommended to take at 11 years old and that is when the Gardasil vaccine was also recommended.
Those who opted not to give their children the Gardasil vaccine expressed their fears of the safety of the new vaccine. Another reason some parents chose to wait was because it was expensive, the cost is $375. Many parents believed that it could wait a couple more years before their children were sexually active.
The Centers for Disease Control and Prevention wanted to see higher rates for the Gardasil vaccine because it can dramatically reduce the amount of deaths that occur from cervical cancer, a complication of the human papillomavirus. There are currently about 3,000 deaths per year from cervical cancer. Since this is important in preventing deaths health officials are pushing for promotion of this vaccination.
Analysis of Health Problem
In analyzing this article the major stakeholders and losers are teenage girls who are not receiving the Gardasil vaccination. Advantages of receiving the Gardasil vaccination is that it is the only one that protects against 4 types of human papillomavirus. Two types of HPV that it guards against cause about 70% of cervical cancer cases. The other...